| Dermatology | Lifetime | 25 | US 13 | 99.79 |
| Occupational Therapy | Lifetime | 21 | US 8 | 99.63 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 238 | US 133 | 99.28 |
| Rehabilitation | Lifetime | 87 | US 44 | 98.94 |
| Immunology and Allergy | Lifetime | 349 | US 143 | 94.71 |
| Dermatology | 2021-2025 | 62 | US 20 | 98.76 |
| Immunology | 2021-2025 | 852 | US 313 | 70.08 |
| Diabetic Foot Ulcer Assessment and Management | Lifetime | 8 | US 5 | 99.85 |
| Wound Healing and Treatments | Lifetime | 10 | US 6 | 99.83 |
| Pressure Ulcer Prevention and Management | Lifetime | 4 | US 3 | 99.77 |
| Diagnosis and Treatment of Venous Diseases | Lifetime | 8 | US 5 | 99.68 |
| Dermatology and Skin Diseases | Lifetime | 34 | US 18 | 99.73 |
| Acne and Rosacea Treatments and Effects | Lifetime | 15 | US 7 | 99.35 |
| Allergic Rhinitis and Sensitization | Lifetime | 87 | US 28 | 99.51 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 500 | US 207 | 98.59 |
| Food Allergy and Anaphylaxis Research | Lifetime | 184 | US 63 | 98.52 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 197 | US 67 | 98.34 |
| Asthma and respiratory diseases | Lifetime | 945 | US 330 | 98.04 |
| Peripheral Artery Disease Management | Lifetime | 716 | US 392 | 96.34 |
| Nail Diseases and Treatments | Lifetime | 782 | US 298 | 94.58 |
| Dermatological diseases and infestations | Lifetime | 263 | US 123 | 92.88 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 824 | US 321 | 93.30 |
| Drug-Induced Adverse Reactions | Lifetime | 748 | US 227 | 92.19 |
| Skin Diseases and Diabetes | Lifetime | 391 | US 148 | 89.60 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 314 | US 84 | 85.39 |
| Otolaryngology and Infectious Diseases | Lifetime | 596 | US 228 | 82.84 |
| Dermatology and Skin Diseases | 2021-2025 | 143 | US 38 | 97.77 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 258 | US 72 | 95.60 |
| Skin Diseases and Diabetes | 2021-2025 | 36 | US 16 | 87.81 |
| Asthma and respiratory diseases | 2021-2025 | 736 | US 185 | 93.30 |
| Urticaria and Related Conditions | 2021-2025 | 274 | US 57 | 90.24 |
| Diabetic Foot Ulcer Assessment and Management | 2021-2025 | 458 | US 114 | 86.55 |
| Food Allergy and Anaphylaxis Research | 2021-2025 | 557 | US 142 | 86.72 |
| Acne and Rosacea Treatments and Effects | 2021-2025 | 229 | US 52 | 81.95 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 248 | US 76 | 82.65 |
| Contact Dermatitis and Allergies | 2021-2025 | 418 | US 103 | 81.94 |
| Oral Health Pathology and Treatment | 2021-2025 | 552 | US 57 | 79.41 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 950 | US 306 | 73.82 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 826 | US 313 | 73.88 |
| Pressure Ulcer Prevention and Management | 2021-2025 | 499 | US 104 | 69.94 |
| Hidradenitis Suppurativa and Treatments | 2021-2025 | 455 | US 144 | 65.15 |
